125 related articles for article (PubMed ID: 2692970)
1. Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?
Parr SN
Curr Med Res Opin; 1989; 11(9):557-66. PubMed ID: 2692970
[TBL] [Abstract][Full Text] [Related]
2. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Nyrén O; Adami HO; Bates S; Bergström R; Gustavsson S; Lööf L; Nyberg A
N Engl J Med; 1986 Feb; 314(6):339-43. PubMed ID: 3511376
[TBL] [Abstract][Full Text] [Related]
3. Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre study.
Farup PG; Weberg R; Berstad A; Wetterhus S; Dahlberg O; Dybdahl J; Fyllingen G; Kannelønning KS; Lange OJ
Scand J Gastroenterol; 1990 Mar; 25(3):315-20. PubMed ID: 2181623
[TBL] [Abstract][Full Text] [Related]
4. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin.
Gotthard R; Bodemar G; Brodin U; Jönsson KA
Scand J Gastroenterol; 1988 Jan; 23(1):7-18. PubMed ID: 3278366
[TBL] [Abstract][Full Text] [Related]
5. The emergency department treatment of dyspepsia with antacids and oral lidocaine.
Welling LR; Watson WA
Ann Emerg Med; 1990 Jul; 19(7):785-8. PubMed ID: 2202240
[TBL] [Abstract][Full Text] [Related]
6. Low-dose antacids or cimetidine for duodenal ulcer?
Weberg R; Aubert E; Dahlberg O; Dybdahl J; Ellekjaer E; Farup PG; Hovdenak N; Lange O; Melsom M; Stallemo A
Gastroenterology; 1988 Dec; 95(6):1465-9. PubMed ID: 3053312
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study.
Singal AK; Kumar A; Broor SL
Curr Med Res Opin; 1989; 11(6):390-7. PubMed ID: 2651015
[TBL] [Abstract][Full Text] [Related]
8. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study.
Petrokubi RJ; Jeffries GH
Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trial.
Ippoliti AF; Sturdevant RA; Isenberg JI; Binder M; Camacho R; Cano R; Cooney C; Kline MM; Koretz RL; Meyer JH; Samloff IM; Schwabe AD; Strom EA; Valenzuela JE; Wintroub RH
Gastroenterology; 1978 Feb; 74(2 Pt 2):393-5. PubMed ID: 340327
[TBL] [Abstract][Full Text] [Related]
10. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
[TBL] [Abstract][Full Text] [Related]
11. Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy.
Collen MJ; Hanan MR; Maher JA; Rent M; Stubrin SE; Arguello JF; Gardner L
Dig Dis Sci; 1980 Oct; 25(10):744-9. PubMed ID: 7000474
[TBL] [Abstract][Full Text] [Related]
12. Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial.
Isenberg JI; Peterson WL; Elashoff JD; Sandersfeld MA; Reedy TJ; Ippoliti AF; Van Deventer GM; Frankl H; Longstreth GF; Anderson DS
N Engl J Med; 1983 Jun; 308(22):1319-24. PubMed ID: 6341844
[TBL] [Abstract][Full Text] [Related]
13. Cimetidine, antacid, and hospitalization in the treatment of benign gastric ulcer: a multicenter double blind study.
Englert E; Freston JW; Graham DY; Finkelstein W; Kruss DM; Priest RJ; Raskin JB; Rhodes JB; Rogers AI; Wenger J; Wilcox LL; Crossley RJ
Gastroenterology; 1978 Feb; 74(2 Pt 2):416-25. PubMed ID: 340332
[TBL] [Abstract][Full Text] [Related]
14. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia.
Kelbaek H; Linde J; Eriksen J; Mungaard S; Moesgaard F; Bonnevie O
Acta Med Scand; 1985; 217(3):281-7. PubMed ID: 3887851
[TBL] [Abstract][Full Text] [Related]
15. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Rappaport BS
N Engl J Med; 1986 Sep; 315(12):763-4. PubMed ID: 3528852
[No Abstract] [Full Text] [Related]
16. Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers.
Ström M; Gotthard R; Bodemar G; Walan A
Scand J Gastroenterol; 1981; 16(5):593-602. PubMed ID: 7034155
[TBL] [Abstract][Full Text] [Related]
17. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.
Behar J; Brand DL; Brown FC; Castell DO; Cohen S; Crossley RJ; Pope CE; Winans CS
Gastroenterology; 1978 Feb; 74(2 Pt 2):441-8. PubMed ID: 340333
[TBL] [Abstract][Full Text] [Related]
18. Why do dyspeptic patients prefer one liquid antacid to another?
Blum AL
Eur J Clin Invest; 1986 Dec; 16(6):515-8. PubMed ID: 3104051
[TBL] [Abstract][Full Text] [Related]
19. Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients.
Priebe HJ; Skillman JJ; Bushnell LS; Long PC; Silen W
N Engl J Med; 1980 Feb; 302(8):426-30. PubMed ID: 6986027
[TBL] [Abstract][Full Text] [Related]
20. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
